
This groundbreaking study investigates the lncRNA BLACAT3's role in hematogenous metastasis in bladder cancer. By revealing its regulatory mechanism involving m6A modification, YBX3 recruitment, and NF-κB signaling activation, the research provides insights into potential therapeutic targets and prognosis prediction tools for advanced bladder cancer patients.
Like
Save
Share